A Simple Scoring System for Predicting In-Hospital Mortality after Heart Valve Surgery in A Developing Country
Abstract
Background: Various scoring systems predict mortality after cardiac surgery, but not many were designed for specific valvular surgery. Developing countries have different characteristics of patients and conditions in cardiac centers compare to developed countries. We aimed to develop a simple scoring system for predicting in-hospital mortality after valve surgery and further validate the scoring system.
Methods: For developing the scoring system, the data was taken from the medical record of patient underwent valve surgery in 2012 - 2014, and for the validation study, it was from 2015 to 2016. The scoring system was developed using logistic regression models, then validated using calibration and discrimination analysis.
Result: For developing a scoring system, we recruited 1040 patients in the study. The in-hospital mortality rate was 68 (6.5%). Eight variables were incorporated, including; functional class, hypertension, previous open-heart surgery, impaired renal function, right ventricular dysfunction, emergent operation, coronary artery bypass surgery, and tricuspid valve surgery. The mortality risk score has Hosmer Lemeshow (H-L) test p-value = 0.212; AUC = 0.813 (CI 95% = 0.758–0.867); and cut-off point of 5, predicting 14% risk of death (sensitivity 72.1%, specificity 75.3%). In the validation study, 789 subjects were recruited. The observed and predicted mortality were 8.6% and 11.9% respectively, with H-L test p-value = 0.169 and AUC 0.761 (95% CI; 0.702-0.821)
Conclusion: We have developed a simple scoring system for predicting in-hospital mortality after valve surgery. The mortality risk score was well-calibrated with a moderate discrimination value in the validation study.
Downloads
References
1. Soesanto AM. Penyakit Jantung Katup di Indonesia: masalah yang hampir terlupakan. Indones J Cardiol. 2012;33(4):205-208. doi:10.30701/ijc.v33i4.20
2. Nashef SAM, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardio-thoracic Surg. 1999;16(1):9-13. doi:10.1016/S1010-7940(99)00134-7
3. Eacts CS, Germany CH, Rosenhek R, et al. 2017 ESC / EACTS Guidelines for the Management of Valvular Heart Disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology ( ESC ) and the European.; 2017. doi:10.1093/eurheartj/ehx391
4. Shahian DM, Blackstone EH, Edwards FH, et al. Cardiac surgery risk models: A position article. Ann Thorac Surg. 2004;78(5):1868-1877. doi:10.1016/j.athoracsur.2004.05.054
5. Nashef SAM, Roques F, Sharples LD, et al. Euroscore II. Eur J Cardio-thoracic Surg. 2012;41(4):734-745. doi:10.1093/ejcts/ezs043
6. O’Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models: Part 2-Isolated Valve Surgery. Ann Thorac Surg. 2009;88(1 SUPPL.):S23-S42. doi:10.1016/j.athoracsur.2009.05.056
7. Shahian DM, Brien SMO, Filardo G, et al. The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models : Part 3 — Valve Plus Coronary Artery Bypass Grafting Surgery. ATS. 2009;88(1):S43-S62. doi:10.1016/j.athoracsur.2009.05.055
8. Parolari A, Pesce LL, Trezzi M, et al. EuroSCORE Performance in Valve Surgery: A Meta-Analysis. Ann Thorac Surg. 2010;89(3):787-793.e2. doi:10.1016/j.athoracsur.2009.11.032
9. Barili F, Pacini D, Grossi C, Bartolomeo D, Alamanni F, Parolari A. Reliability of new scores in predicting perioperative mortality after mitral valve surgery. J Thorac Cardiovasc Surg. 2014;147(3):1008-1012. doi:10.1016/j.jtcvs.2013.06.042
10. Rosenhek R, Iung B, Tornos P, et al. ESC working group on valvular heart disease position paper: Assessing the risk of interventions in patients with valvular heart disease. Eur Heart J. 2012;33(7):822-828. doi:10.1093/eurheartj/ehr061
11. Verheul HA, van den Brink RBA, Bouma BJ, et al. Analysis of risk factors for excess mortality after aortic valve replacement. J Am Coll Cardiol. 1995;26(5):1280-1286. doi:10.1016/0735-1097(95)00303-7
12. Asimakopoulos G, Edwards MB, Brannan J, Taylor KM. Survival and cause of death after mitral valve replacement in patients aged 80 years and over: Collective results from the UK heart valve registry. Eur J Cardio-thoracic Surg. 1997;11(5):922-928. doi:10.1016/S1010-7940(97)01206-2
13. Bernstein AD, Parsonnet V. Bedside estimation of risk as an aid for decision-making in cardiac surgery. Ann Thorac Surg. 2000;69(3):823-828. doi:10.1016/S0003-4975(99)01424-1
14. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: Pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008;117(13):1717-1731. doi:10.1161/CIRCULATIONAHA.107.653584
15. Haddad F, Couture P, Tousignant C, Denault AY. The right ventricle in cardiac surgery, a perioperative perspective: I. anatomy, physiology, and assessment. Anesth Analg. 2009;108(2):407-421. doi:10.1213/ane.0b013e31818f8623
16. Malouf JF, Enriquez-Sarano M, Pellikka PA, et al. Severe pulmonary hypertension in patients with severe aortic valve stenosis: Clinical profile and prognostic implications. J Am Coll Cardiol. 2002;40(4):789-795. doi:10.1016/S0735-1097(02)02002-8
17. Melby SJ, Moon MR, Lindman BR, Bailey MS, Hill LL, Damiano RJ. Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg. 2011;141(6):1424-1430. doi:10.1016/j.jtcvs.2011.02.028
18. Mubeen M, Singh AK, Agarwal SK, Pillai J, Kapoor S, Srivastava AK. Mitral valve replacement in severe pulmonary arterial hypertension. Asian Cardiovasc Thorac Ann. 2008;16(1):37-42. doi:10.1177/021849230801600110
19. Rosenkranz S, Bonderman D, Buerke M, et al. Pulmonary hypertension due to left heart disease: Updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol. 2011;154(SUPPL. 1):S34-S44. doi:10.1016/S0167-5273(11)70491-0
20. Gali N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2009;30(20):2493-2537. doi:10.1093/eurheartj/ehp297
21. Denault A, Deschamps A, Tardif JC, Lambert J, Perrault L. Pulmonary hypertension in cardiac surgery. Current cardiology reviews 2010;6(1):1-14 doi: 10.2174/157340310790231671[published Online First: Epub Date]|
22. Voelkel NF, Quaife RA, Leinwand LA, et al. Right ventricular function and failure: Report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006;114(17):1883-1891. doi:10.1161/CIRCULATIONAHA.106.632208
Full Text (PDF) downloads: 864
Copyright (c) 2022 Indonesian Journal of Cardiology
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
